Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy.

MLA

Brown, Stephen M., et al. “Onasemnogene‐abeparvovec Administration to Premature Infants with Spinal Muscular Atrophy.” Annals of Clinical & Translational Neurology, Sept. 2024, p. 1. EBSCOhost, https://doi.org/10.1002/acn3.52213.

APA

Brown, S. M., Ajjarapu, A. S., Ramachandra, D., Blasco, P. L., Costa, R. M., Tizzano, E. F., Sumner, C. J., & Mathews, K. D. (2024). Onasemnogene‐abeparvovec administration to premature infants with spinal muscular atrophy. Annals of Clinical & Translational Neurology, 1. https://doi.org/10.1002/acn3.52213

Chicago

Brown, Stephen M., Aparna S. Ajjarapu, Divya Ramachandra, Pérez, Laura Blasco, Roger, Mar Costa, Eduardo F. Tizzano, Charlotte J. Sumner, and Katherine D. Mathews. 2024. “Onasemnogene‐abeparvovec Administration to Premature Infants with Spinal Muscular Atrophy.” Annals of Clinical & Translational Neurology, September, 1. doi:10.1002/acn3.52213.